Dr. Kristopher Kaliebe presents as a largely unknown quantity in the expert witness arena, with minimal public credentials or institutional affiliations on record. His specialty area remains unidentified, making it difficult to assess his qualifications or methodology. The lack of available background information suggests either a new entrant to expert testimony or someone operating with a deliberately low profile in the litigation space. Kaliebe's courtroom track record is extremely limited, appearing only in the 3M Earplugs litigation in Boe v. Marshall in the Middle District of Alabama in April 2022. The case data shows conflicting entries but confirms at least one defense-side engagement in this mass tort, which involved hearing loss claims against 3M's Combat Arms Earplugs. His classification as "primarily defense-side" based on this single known engagement suggests he may be positioned to support defendants in product liability cases, though the sample size is too small for reliable pattern analysis. For plaintiff attorneys, Kaliebe represents both an opportunity and a significant unknown. The absence of any Daubert challenges cuts both ways—while there are no recorded exclusions to exploit, there's also no established track record of judicial acceptance of his testimony. His apparent inexperience in high-stakes litigation could make him vulnerable to aggressive cross-examination about his qualifications, methodology, and limited courtroom exposure. Plaintiff counsel should conduct thorough background research before engaging him and consider whether his unknown credentials could undermine case credibility. If opposing him, focus discovery on his actual qualifications, the basis for his opinions, and his limited litigation experience to potentially expose weaknesses in his expert foundation.
No Daubert challenges on record.
Free during beta. Your inquiry will be sent to MTAA and the expert if they've claimed their profile.
We'll send a verification link to your email. Once verified you can add contact info, bio, and availability.